From: Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
SNP | A1 | Mayo cohort | ADGC cohort | Mayo + ADGC | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | MAF_A | MAF_U | OR | 95% CI | P | N | MAF_A | MAF_U | OR | 95% CI | P | N | MAF_A | MAF_U | OR | 95% CI | P | ||
rs1467967 | G | 4,986 | 0.335 | 0.330 | 1.10 | 0.99 - 1.22 | 0.079 | 14,365 | 0.329 | 0.327 | 1.05 | 0.99 - 1.11 | 0.102 | 19,351 | 0.330 | 0.327 | 1.05 | 1.00 - 1.10 | 0.062 |
rs242557 | A | 4,935 | 0.377 | 0.379 | 1.00 | 0.90 - 1.11 | 0.988 | 13,407 | 0.358 | 0.356 | 1.01 | 0.95 - 1.07 | 0.721 | 18,342 | 0.363 | 0.364 | 1.00 | 0.95 - 1.05 | 0.974 |
rs3785883 | A | 5,247 | 0.182 | 0.183 | 1.07 | 0.95 - 1.22 | 0.274 | 15,187 | 0.178 | 0.171 | 1.08 | 1.01 - 1.15 | 0.032 | 20,434 | 0.179 | 0.175 | 1.06 | 1.01 - 1.13 | 0.034 |
rs2471738 | T | 5,282 | 0.223 | 0.209 | 1.07 | 0.95 - 1.21 | 0.250 | 14,181 | 0.207 | 0.201 | 1.05 | 0.98 - 1.12 | 0.194 | 19,463 | 0.209 | 0.203 | 1.05 | 0.99 - 1.11 | 0.109 |
rs8070723 | G | 5,129 | 0.209 | 0.222 | 0.81 | 0.71 - 0.91 | 7.0E-04 | 15,895 | 0.211 | 0.221 | 0.89 | 0.84 - 0.94 | 1.3E-04 | 21,024 | 0.211 | 0.221 | 0.90 | 0.85 - 0.95 | 5.3E-05 |
rs7521 | A | 5,171 | 0.458 | 0.457 | 1.08 | 0.97 - 1.19 | 0.152 | 15,656 | 0.466 | 0.468 | 1.02 | 0.97 - 1.07 | 0.529 | 20,827 | 0.465 | 0.465 | 1.02 | 0.97 - 1.06 | 0.437 |